Abstract | BACKGROUND: Emergency department (ED) management of hereditary angioedema (HAE) has been hindered by misdiagnosis and limited treatment options. Food and Drug Administration approval of 4 on-demand HAE therapies starting in 2009 and the publication of ED guidelines for angioedema management in 2014 should facilitate improvement of HAE management in the ED. OBJECTIVE: The objective of this study was to identify patient-reported areas for improvement in ED management of HAE attacks. METHODS: Patients with self-reported HAE with C1 inhibitor deficiency who attended the 2015 HAE Association Patient Summit were asked to complete an anonymous 30-question survey. Questions addressed patient characteristics and HAE management in the ED. RESULTS: Patients indicated that understanding of HAE in the ED needed improvement (99%, 104 of 105 patients). Recognition of HAE as a diagnosis (48%, 50 of 105 patients), appreciation of HAE as a serious disease (45%, 47 of 105 patients), and medication management (59%, 62 of 105 patients) were identified as areas needing improvement. Among 39 patients who required ED care within the last year, 6 did not receive any HAE-targeted therapy, and treatment with corticosteroids (n = 3), epinephrine (n = 2), and antihistamines (n = 7) was reported. Among 68 patients whose treatment plan was to receive home on-demand therapy, 26 required ED care because of an inability to receive on-demand therapy at home as outlined in their treatment plan. Having a treatment plan was associated with a greater likelihood of receiving HAE therapy in the ED (99% vs 74%, P = .002). CONCLUSION: HAE management in the ED can be improved with a focus on recognition of HAE attacks and administration of effective HAE therapies.
|
Authors | Iris M Otani, Sandra C Christiansen, Paula Busse, Carlos A Camargo Jr, Bruce L Zuraw, Marc A Riedl, Aleena Banerji |
Journal | The journal of allergy and clinical immunology. In practice
(J Allergy Clin Immunol Pract)
2017 Jan - Feb
Vol. 5
Issue 1
Pg. 128-134.e4
ISSN: 2213-2201 [Electronic] United States |
PMID | 27665386
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved. |
Topics |
- Adolescent
- Angioedemas, Hereditary
(diagnostic imaging, epidemiology, therapy)
- Child
- Child, Preschool
- Diagnostic Errors
- Disease Management
- Emergency Medical Services
- Emergency Service, Hospital
- Female
- Humans
- Infant
- Infant, Newborn
- Male
- Patient Satisfaction
- Practice Guidelines as Topic
- Quality Assurance, Health Care
- Quality Improvement
- Surveys and Questionnaires
- United States
- United States Food and Drug Administration
|